logo
logo

Natera Acquires Reproductive Health Assets from Invitae

Natera Acquires Reproductive Health Assets from Invitae

01/22/24, 12:09 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgaustin
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan francisco
Industry
biotechnology research
biotechnology
Natera, Inc. has acquired certain assets related to non-invasive prenatal screening and carrier screening business from Invitae, a leading medical genetics company. This strategic acquisition is aligned with Natera’s commitment to providing excellent service and aims to support additional patients and providers.

Company Info

Company
Natera
Location
Austin, Texas, United States
Company info
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.

Related People